/TMDIF

TMDIF Stock - Titan Medical Inc.

Q: What is the analyst price target for TMDIF?

Analyst price target information is not currently available for TMDIF.

Q: What is TMDIF's market cap?

Market capitalization information is not currently available for TMDIF.

Healthcare|Medical - Devices|OTC

$0.82+2173.99%

+$0.78 (+2173.99%) • Oct 15

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.90

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TMDIF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.98

52W High$1.00

52W Low$0.03

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$17.96M	N/A	$19.92M	$21.06M	N/A
Gross Profit	$17.77M	$-825,924	$19.92M	$21.06M	$-33,311
Gross Margin	98.9%	N/A	100.0%	100.0%	N/A
Operating Income	$10.31M	$-42,997,051	$-30,714,343	$4.42M	$-60,643,146
Net Income	$6.95M	$-40,856,371	$-14,727,264	$-25,462,251	$-42,881,355
Net Margin	38.7%	N/A	-73.9%	-120.9%	N/A
EPS	$0.06	$-0.37	$-0.14	$-0.38	$-1.40

Company Overview

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

Visit Website

Earnings History & Surprises

TMDIF

Beat Rate

58%

Last 12 quarters

Avg Surprise

+39.9%

EPS vs Estimate

Beats / Misses

7/5

Last 12 quarters

Latest EPS

$-0.25

Q3 2024

EPS Surprise History

Q4 22

+96.8%

$-0.09vs$-2.75

Q2 23

No data

Q2 23

+8.3%

$-2.75vs$-3.00

Q3 23

+175.0%

$2.25vs$-3.00

Q4 23

+100.0%

$0.00vs$-3.25

Q1 24

-11.1%

$-0.10vs$-0.09

Q2 24

No data

Q3 24

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2024	Aug 15, 2024	—	$-0.25	—	—
Q2 2024	Apr 1, 2024	—	$-0.75	—	—
Q1 2024	Mar 27, 2024	$-0.09	$-0.10	-11.1%	✗ MISS
Q4 2023	Nov 2, 2023	$-3.25	$0.00	+100.0%	✓ BEAT
Q3 2023	Aug 10, 2023	$-3.00	$2.25	+175.0%	✓ BEAT
Q2 2023	May 31, 2023	$-3.00	$-2.75	+8.3%	✓ BEAT
Q2 2023	May 12, 2023	—	$-0.11	—	—
Q4 2022	Nov 10, 2022	$-2.75	$-0.09	+96.8%	✓ BEAT
Q3 2022	Aug 11, 2022	$-0.09	$-0.10	-11.1%	✗ MISS
Q2 2022	May 12, 2022	$-0.10	$-0.08	+20.0%	✓ BEAT
Q1 2022	Mar 24, 2022	$-0.13	$0.08	+161.5%	✓ BEAT
Q4 2021	Nov 11, 2021	$-0.06	$-0.08	-33.3%	✗ MISS
Q3 2021	Aug 11, 2021	$-0.01	$-0.01	-66.7%	✗ MISS
Q2 2021	May 17, 2021	$-0.10	$-0.15	-50.0%	✗ MISS
Q1 2021	Feb 22, 2021	—	—	—	—
Q4 2020	Nov 16, 2020	—	—	—	—
Q3 2020	Aug 12, 2020	—	—	—	—
Q2 2020	May 13, 2020	—	—	—	—
Q1 2020	Mar 30, 2020	$-0.19	—	—	—
Q4 2019	Nov 15, 2019	$-0.47	$-0.05	+89.4%	✓ BEAT